C

Co-Diagnostics
D

CODX

0.32500
USD
-0.06
(-15.01%)
مغلق
حجم التداول
831
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
10,377,169
أصول ذات صلة
A
AEMD
-0.02980
(-7.95%)
0.34500 USD
B
BNGO
-0.49000
(-12.83%)
3.33000 USD
I
IBIO
-0.30500
(-7.43%)
3.80000 USD
I
INO
-0.06500
(-3.93%)
1.59000 USD
L
LAKE
-2.060
(-10.01%)
18.520 USD
MRNA
MRNA
-2.020
(-7.29%)
25.700 USD
N
NVAX
-0.38500
(-6.44%)
5.59500 USD
O
OPK
-0.07500
(-4.53%)
1.58000 USD
V
VIR
-0.53000
(-8.17%)
5.96000 USD
المزيد
الأخبار المقالات

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.